Cross reactivity of serological response to SARS-CoV-2 vaccination with viral variants of concern detected by lateral flow immunoassays. (2021)

First Author: Ebanks D
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2021.07.020

PubMed Identifier: 34324939

Publication URI: http://europepmc.org/abstract/MED/34324939

Type: Journal Article/Review

Volume: 83

Parent Publication: The Journal of infection

Issue: 4

ISSN: 0163-4453